These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 11847009)

  • 1. Ex vivo expansion of stem and progenitor cells in co-culture of mobilized peripheral blood CD34+ cells on human endothelium transfected with adenovectors expressing thrombopoietin, c-kit ligand, and Flt-3 ligand.
    Feugier P; Jo DY; Shieh JH; MacKenzie KL; Rafii S; Crystal RG; Moore MA
    J Hematother Stem Cell Res; 2002 Feb; 11(1):127-38. PubMed ID: 11847009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteopetrotic mouse stroma with thrombopoietin, c-kit ligand, and flk-2 ligand supports long-term mobilized CD34+ hematopoiesis in vitro.
    Feugier P; Li N; Jo DY; Shieh JH; MacKenzie KL; Lesesve JF; Latger-Cannard V; Bensoussan D; Crystal RG; Rafii S; Stoltz JF; Moore MA
    Stem Cells Dev; 2005 Oct; 14(5):505-16. PubMed ID: 16305336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human stem-progenitor cells from neonatal cord blood have greater hematopoietic expansion capacity than those from mobilized adult blood.
    Tanavde VM; Malehorn MT; Lumkul R; Gao Z; Wingard J; Garrett ES; Civin CI
    Exp Hematol; 2002 Jul; 30(7):816-23. PubMed ID: 12135681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. flt-3 ligand is more potent than c-kit ligand for the synergistic stimulation of ex vivo hematopoietic cell expansion.
    Koller MR; Oxender M; Brott DA; Palsson BO
    J Hematother; 1996 Oct; 5(5):449-59. PubMed ID: 8938517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD34+ cells from mobilized peripheral blood retain fetal bone marrow repopulating capacity within the Thy-1+ subset following cell division ex vivo.
    Young JC; Lin K; Hansteen G; Travis M; Murray LJ; Jaing L; Scollay R; Hill BL
    Exp Hematol; 1999 Jun; 27(6):994-1003. PubMed ID: 10378888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombopoietin augments ex vivo expansion of human cord blood-derived hematopoietic progenitors in combination with stem cell factor and flt3 ligand.
    Ohmizono Y; Sakabe H; Kimura T; Tanimukai S; Matsumura T; Miyazaki H; Lyman SD; Sonoda Y
    Leukemia; 1997 Apr; 11(4):524-30. PubMed ID: 9096693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human umbilical vein endothelial cells increase ex vivo expansion of human CD34(+) PBPC through IL-6 secretion.
    Li N; Eljaafari A; Bensoussan D; Wang Y; Latger-Cannard V; Serrurier B; Boura C; Kennel A; Stoltz J; Feugier P
    Cytotherapy; 2006; 8(4):335-42. PubMed ID: 16923609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flt 3 ligand, MGDF, Epo and G-CSF enhance ex vivo expansion of hematopoietic cell compartments in the presence of SCF, IL-3 and IL-6.
    Kobari L; Giarratana MC; Poloni A; Firat H; Labopin M; Gorin NC; Douay L
    Bone Marrow Transplant; 1998 Apr; 21(8):759-67. PubMed ID: 9603398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of Flk-2/flt3 ligand as compared with c-kit ligand on short-term and long-term proliferation of CD34+ hematopoietic progenitors elicited from human fetal liver, umbilical cord blood, bone marrow, and mobilized peripheral blood.
    Shapiro F; Pytowski B; Rafii S; Witte L; Hicklin DJ; Yao TJ; Moore MA
    J Hematother; 1996 Dec; 5(6):655-62. PubMed ID: 9117254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombopoietin directly and potently stimulates multilineage growth and progenitor cell expansion from primitive (CD34+ CD38-) human bone marrow progenitor cells: distinct and key interactions with the ligands for c-kit and flt3, and inhibitory effects of TGF-beta and TNF-alpha.
    Ramsfjell V; Borge OJ; Cui L; Jacobsen SE
    J Immunol; 1997 Jun; 158(11):5169-77. PubMed ID: 9164933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
    Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
    Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of recombinant human thrombopoietin alone and in combination with erythropoietin and early-acting cytokines on human mobilized purified CD34+ progenitor cells cultured in serum-depleted medium.
    Birkmann J; Oez S; Smetak M; Kaiser G; Kappauf H; Gallmeier WM
    Stem Cells; 1997; 15(1):18-32. PubMed ID: 9007219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful short-term ex vivo expansion of NOD/SCID repopulating ability and CAFC week 6 from umbilical cord blood.
    Kusadasi N; van Soest PL; Mayen AE; Koevoet JL; Ploemacher RE
    Leukemia; 2000 Nov; 14(11):1944-53. PubMed ID: 11069030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal through gp130 activated by soluble interleukin (IL)-6 receptor (R) and IL-6 or IL-6R/IL-6 fusion protein enhances ex vivo expansion of human peripheral blood-derived hematopoietic progenitors.
    Kimura T; Wang J; Minamiguchi H; Fujiki H; Harada S; Okuda K; Kaneko H; Yokota S; Yasukawa K; Abe T; Sonoda Y
    Stem Cells; 2000; 18(6):444-52. PubMed ID: 11072033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of progenitor enrichment, serum, and cytokines on the ex vivo expansion of mobilized peripheral blood stem cells: a controlled trial.
    Balducci E; Azzarello G; Valenti MT; Capuzzo GM; Pappagallo GL; Pilotti I; Ausoni S; Bari M; Rosetti F; Sartori D; Ciappa A; Porcellini A; Vinante O
    Stem Cells; 2003; 21(1):33-40. PubMed ID: 12529549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic delineation of optimal cytokine concentrations to expand hematopoietic stem/progenitor cells in co-culture with mesenchymal stem cells.
    Andrade PZ; dos Santos F; Almeida-Porada G; da Silva CL; S Cabral JM
    Mol Biosyst; 2010 Jul; 6(7):1207-15. PubMed ID: 20424784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a cytokine combination including thrombopoietin for improved transduction of a retroviral gene into G-CSF-mobilized CD34+ human blood cells.
    Kim HJ; Okamoto Y; Ito M; Takaue Y; Kawano Y; Watanabe T; Yamaue T; Tohda Y; Ogose T; Shimada T; Shimosaka A; Kuroda Y
    Stem Cells; 1997; 15(5):347-52. PubMed ID: 9323796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transduction of CD34+ cells with lentiviral vectors enables the production of large quantities of transgene-expressing immature and mature dendritic cells.
    Salmon P; Arrighi JF; Piguet V; Chapuis B; Zubler RH; Trono D; Kindler V
    J Gene Med; 2001; 3(4):311-20. PubMed ID: 11529660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of addition of FLT-3 ligand and megakaryocyte growth and development factor on hemopoietic cells in serum-free conditions.
    Rossi B; Zanolin E; Vincenzi C; Diani F; Pizzolo G; de Wynter E; Nadali G
    Stem Cells Dev; 2004 Aug; 13(4):362-71. PubMed ID: 15345130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.